1e2s Citations

Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis.

J Mol Biol 305 269-77 (2001)
Related entries: 1e1z, 1e3c

Cited: 56 times
EuropePMC logo PMID: 11124905

Abstract

Arylsulfatase A (ASA) belongs to the sulfatase family whose members carry a C(alpha)-formylglycine that is post-translationally generated by oxidation of a conserved cysteine or serine residue. The crystal structures of two arylsulfatases, ASA and ASB, and kinetic studies on ASA mutants led to different proposals for the catalytic mechanism in the hydrolysis of sulfate esters. The structures of two ASA mutants that lack the functional C(alpha)-formylglycine residue 69, in complex with a synthetic substrate, have been determined in order to unravel the reaction mechanism. The crystal structure of the inactive mutant C69A-ASA in complex with p-nitrocatechol sulfate (pNCS) mimics a reaction intermediate during sulfate ester hydrolysis by the active enzyme, without the covalent bond to the key side-chain FGly69. The structure shows that the side-chains of lysine 123, lysine 302, serine 150, histidine 229, the main-chain of the key residue 69 and the divalent cation in the active center are involved in sulfate binding. It is proposed that histidine 229 protonates the leaving alcoholate after hydrolysis.C69S-ASA is able to bind covalently to the substrate and hydrolyze it, but is unable to release the resulting sulfate. Nevertheless, the resulting sulfation is low. The structure of C69S-ASA shows the serine side-chain in a single conformation, turned away from the position a substrate occupies in the complex. This suggests that the double conformation observed in the structure of wild-type ASA is more likely to correspond to a formylglycine hydrate than to a twofold disordered aldehyde oxo group, and accounts for the relative inertness of the C69S-ASA mutant. In the C69S-ASA-pNCS complex, the substrate occupies the same position as in the C69A-ASA-pNCS complex, which corresponds to the non-covalently bonded substrate. Based on the structural data, a detailed mechanism for sulfate ester cleavage is proposed, involving an aldehyde hydrate as the functional group.

Articles - 1e2s mentioned but not cited (6)

  1. Recon3D enables a three-dimensional view of gene variation in human metabolism. Brunk E, Sahoo S, Zielinski DC, Altunkaya A, Dräger A, Mih N, Gatto F, Nilsson A, Preciat Gonzalez GA, Aurich MK, Prlić A, Sastry A, Danielsdottir AD, Heinken A, Noronha A, Rose PW, Burley SK, Fleming RMT, Nielsen J, Thiele I, Palsson BO. Nat Biotechnol 36 272-281 (2018)
  2. Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase. Ulmer JE, Vilén EM, Namburi RB, Benjdia A, Beneteau J, Malleron A, Bonnaffé D, Driguez PA, Descroix K, Lassalle G, Le Narvor C, Sandström C, Spillmann D, Berteau O. J Biol Chem 289 24289-24303 (2014)
  3. Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity. Kowalewski B, Lübke T, Kollmann K, Braulke T, Reinheckel T, Dierks T, Damme M. J Biol Chem 289 27992-28005 (2014)
  4. A new definition and properties of the similarity value between two protein structures. Saberi Fathi SM. J Biol Phys 42 621-636 (2016)
  5. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  6. Structural insights into choline-O-sulfatase reveal the molecular determinants for ligand binding. Gavira JA, Cámara-Artigas A, Neira JL, Torres de Pinedo JM, Sánchez P, Ortega E, Martinez-Rodríguez S. Acta Crystallogr D Struct Biol 78 669-682 (2022)


Reviews citing this publication (13)

  1. Protein posttranslational modifications: the chemistry of proteome diversifications. Walsh CT, Garneau-Tsodikova S, Gatto GJ. Angew Chem Int Ed Engl 44 7342-7372 (2005)
  2. Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Hanson SR, Best MD, Wong CH. Angew Chem Int Ed Engl 43 5736-5763 (2004)
  3. A review of coumarin derivatives in pharmacotherapy of breast cancer. Musa MA, Cooperwood JS, Khan MO. Curr Med Chem 15 2664-2679 (2008)
  4. The heparanome--the enigma of encoding and decoding heparan sulfate sulfation. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CL, Dierks T. J Biotechnol 129 290-307 (2007)
  5. Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications. Appel MJ, Bertozzi CR. ACS Chem Biol 10 72-84 (2015)
  6. Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches. Shaimardanova AA, Chulpanova DS, Solovyeva VV, Mullagulova AI, Kitaeva KV, Allegrucci C, Rizvanov AA. Front Med (Lausanne) 7 576221 (2020)
  7. Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. Lai JP, Thompson JR, Sandhu DS, Roberts LR. Future Oncol 4 803-814 (2008)
  8. Developing therapeutic approaches for metachromatic leukodystrophy. Patil SA, Maegawa GH. Drug Des Devel Ther 7 729-745 (2013)
  9. Metabolic functions of the human gut microbiota: the role of metalloenzymes. Rajakovich LJ, Balskus EP. Nat Prod Rep 36 593-625 (2019)
  10. SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects. Potter BVL. J Mol Endocrinol 61 T233-T252 (2018)
  11. Human recombinant lysosomal enzymes produced in microorganisms. Espejo-Mojica ÁJ, Alméciga-Díaz CJ, Rodríguez A, Mosquera Á, Díaz D, Beltrán L, Díaz S, Pimentel N, Moreno J, Sánchez J, Sánchez OF, Córdoba H, Poutou-Piñales RA, Barrera LA. Mol Genet Metab 116 13-23 (2015)
  12. Structural aspects of therapeutic enzymes to treat metabolic disorders. Kang TS, Stevens RC. Hum Mutat 30 1591-1610 (2009)
  13. New Insights into the Plutella xylostella Detoxifying Enzymes: Sequence Evolution, Structural Similarity, Functional Diversity, and Application Prospects of Glucosinolate Sulfatases. Chen W, Amir MB, Liao Y, Yu H, He W, Lu Z. J Agric Food Chem 71 10952-10969 (2023)

Articles citing this publication (37)